Navigation Links
Michigan State Medical Society Says Rate Drop Shows Tort Reform is Working
Date:11/20/2007

DETROIT, Nov. 20 /PRNewswire-USNewswire/ -- A clear indication that Michigan's 1993 tort reforms are working is that the state's largest physician medical malpractice insurer is cutting its premiums by 12 to 25 percent for Wayne County physicians, the Michigan State Medical Society (MSMS) announced today at a news conference in Detroit.

The average decrease for all physicians in Wayne County will be 13 percent beginning January 1, according to American Physicians Assurance Corporation, a medical liability insurer based in East Lansing that is a wholly-owned subsidiary of the publicly held American Physicians Capital, Inc. (APCapital).

Statewide, American Physicians' malpractice insurance rates will be reduced by an average of 6.5 percent in 2008.

"Michigan's carefully designed tort reforms do not deny a truly injured patient from just compensation," said Sophie J. Womack, MD, a Detroit neonatalogist who serves as president of the Wayne County Medical Society of Southeast Michigan and as a member of the MSMS board of directors. "The reforms have helped reduce the 'lottery mentality' of each mal-occurrence, or bad outcome, from becoming a lawsuit."

"Let me put this in perspective," said Robert J. Jackson, MD, an Allen Park family physician and a member of the American Physicians Advisory Board. "Rates for my specialty, family practice, will go down 14 percent. Nothing in the overhead costs of my practice is going down, except, unbelievably, the cost of my malpractice insurance.

"If this isn't evidence that Michigan's tort reforms are working, I don't know what is," Doctor Jackson said.

Doctor Jackson said that obstetricians will see a 14 percent reduction and orthopedic surgeons will see a 25 percent reduction.

"Even neurosurgeons, who perform very high risk procedures, will see a 12 percent cut," Doctor Jackson said.

Since the tort reforms went into effect in 1994, each component of the legislation has wi
'/>"/>

SOURCE Michigan State Medical Society
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
2. Education Key Focus of Michigan Policy Summit
3. Michigan Hospitals Receive Governors Award
4. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
5. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
6. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
7. Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care
8. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
9. Blue Cross Blue Shield of Michigan Launches Effort in Five Michigan Cities with Department of Community Health to Enroll Uninsured Children in MIChild
10. Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program
11. NanoBio Wins 2007 Michigan Innovation Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...k in the Journal of Neurosurgery: Pediatrics fin...cytic Astrocytoma, or JPA, tumors in the thalamus ...r Imaging, or DTI. The sensitivity of DTI imaging...es in the brain. This information can maximize th... avoiding damage to the fiber bundles that are dir...
(Date:12/4/2009)... Corp., a leading manufacturer of over-the-counter...enhance consumers’ quality of life, today an...can Podiatric Medical Association (APMA) Seal of A...iFeet®. , (PRWEB) De...urer of over-the-counter topical cream and first a...
(Date:12/4/2009)..., Dec. 4 , ,What: Humana...care, health benefits provider, is i...agames.com ), a senior-friendly dance pad, ... on Tues., Dec. 8 at 1 p.m. The fes...d open to the public, will feature Dancetown, ...
(Date:12/4/2009)...4 PLUS Diagnostics announced tod...hology services with the launch of a national hema...s the company,s expansion from a regional laborato...y offering diagnostic services across a full range...y and now hematology/oncology. ,, PLUS Diagnos...
(Date:12/4/2009)...PRNewswire/ -- The National Cancer Institute has a...Fred Hutchinson Cancer Research Center to become t...n Service Contact Center. ,, The move will crea...ripling the size of its current CIS workforce - on...hich is scheduled for March 15, 2010. The Seattle ...
Breaking Medicine News(10 mins):Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2
... Smokers who have an easier ...es that can foster success, according to a new stu... Institute on Drug Abuse. , ... according to a new study by a team of federal sci...
...linical pharmacy services can significantly reduce...ewhere in the health care system, according to a n...ois at Chicago. , For every dollar spent by hospi...on errors and other savings, says Glen Schumock, a...
...ing may help unravel how diseases form, , ...ne acting very differently in different tissues ma...w likely a person is to get a disease, a new repor...Such variation can lead to alternative splicing, a...
...y points to 16 states where Medicaid doesn,t fund ... News) -- Thousands of male infants aren,t being c...over the procedure through Medicaid, new research ... policy at the University of California, Los Angel...
...he use of radiation therapy to treat cancer inevit... the benefits of this treatment have been well est...ing complications as a result injury to normal tis.... , A research article to be published on Decemb...
...ing a favorite ritual might ease a friend or famil...lthDay News) -- If a family member or friend is in...r them up by bringing a bit of Christmas from home...ist Hospital in Houston, said in a hospital news r...
Other Medicine News:Health News:Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 2Health News:Genes Seem to Affect Tissues Differently 2Health News:Circumcision Rates Too Low 2Health News:What is the mechanism of the chronic radiation enteritis? 2Health News:Take the Holiday to the Hospital 2
(Date:12/3/2009)... Ted Karkus, Chairman an... www.quigleyco.com announced today that the Comp...ies to develop prescription pharmaceutical and OTC... interests to focus primarily on the OTC/Personal ...mited to its Cold-EEZE® and Kids-EEZE® b...
(Date:12/3/2009)...rk and SAN DIEGO, California, December 3 /PRNewswi...miR-122, a microRNA Important for,Hepatitis C Vira...titis C,Virus in the Bloodstream in Chimpanzees Ch..., - SPC3649 Demonstrates Efficacy With No Evi...vents in the Treated Animals - Signaling a Potenti...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Lure of Bottled Water May Not Be Health Driven 49525 1WellPoint to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 29 2009 49523 1WellPoint to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 29 2009 49523 2Make Nursing Homes More Like Home 3A Medicare 49521 1Make Nursing Homes More Like Home 3A Medicare 49521 2
...ive Insulin-Based Therapies, Market,Growth Will be...om Decision Resource...ne of the,world,s leading research and advisory fi...s that the most significant driver of growth in th...standard of care away from,regular human insulins ...
...09, SEATTLE, Aug. 12 Cell Therapeutics, Inc.,s,(...cine (SM) announced today,that planned enrollment ...rch and Treatment of Cancer (EORTC) randomized pha...ith newly diagnosed advanced or metastatic,soft ti...he primary,endpoint of the trial is progression-fr...
Other Medicine Technology:Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: